
Shiraz |
About
Shiraz | is a hybrid cannabis strain. Lab samples test between 11.7% and 15.8% THC, with caryophyllene (0.76%) as the dominant terpene.
Why does Shiraz | feel pain-relieving?
Shiraz |'s pain-relieving effects are linked to its dominant caryophyllene (0.76%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by humulene (0.40%), associated with appetite suppression and anti-inflammatory effects.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 11.7–15.8%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout Shiraz |
- Shiraz | is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- Shiraz | typically tests at 11.7% to 15.8% THC.
- The dominant terpenes in Shiraz | are Caryophyllene, Humulene, Limonene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.
